Nephrology experts discuss how CKD care has evolved in 2026, including SGLT2 inhibitors, finerenone, GLP-1 receptor agonists, and personalized treatment.
Marc Richards, MD
Advertisement
Marc Richards, MD is a nephrologist at Florida Kidney Physicians, LLC and Director of the FKP Glomerulonephritis Center of Excellence in Boca Raton, Florida.
Articles by Marc Richards, MD
Marc Richards, MD, discusses how new therapies and combination treatment strategies are transforming evidence-based care for chronic kidney disease.
Michael Richards, MD, discusses aldosterone's role in CKD pathophysiology and why targeting this pathway may reshape kidney disease treatment.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
The Future of Gene Silencers for ATTR-CM After CARDIO-TTRansform, With Ronald Witteles, MD
2
ESC Congress 2026: Day 2 Recap—6 Headlines to Know
3
Beyond Edoxaban: Rethinking Stroke Prevention, With Ashkan Shoamanesh, MD
4
AZD5462 Improves Cardiac Function in Phase 2b LUMINARA Trial
5